Low levels of the vitamin D-regulated antimicrobial peptide cathelicidin (LL-37) may negatively impact the immune status of human immunodeficiency virus-1 (HIV-1) infected individuals (HIV+). We compared plasma LL-37 levels in healthy controls (HIV−) and HIV+ individuals on or off antiretroviral therapies (ARTs) (ART+ and ART−, respectively), and evaluated the relationship between vitamin D and LL-37 levels. In this cross-sectional study, levels of LL-37, 25-hydroxycholecalciferol [25(OH)D3] and 1,25-dihydroxycholecalciferol [1,25(OH)2D3] were measured from an initial cohort of 18 healthy controls and 10 HIV+/ART− individuals. Because this cohort lacked HIV+/ART+ subjects, LL-37 was also quantified from a second cohort of 10 HIV+/ART− and 13 HIV+/ART+ individuals. LL-37 levels were significantly lower in the HIV+/ART− group compared to the healthy controls (P = 0.01). A direct relationship was observed between LL-37 and both 25(OH)D3 and 1,25(OH)2D3. The level of 25(OH)D3 was predictive of higher LL-37 (P = 0.04) and for any given level of 25(OH)D3, HIV+/ART− subjects averaged 20 % lower LL-37 compared to the healthy controls (P = 0.045). For any given level of 1,25(OH)2D3, HIV+/ART− subjects averaged 25 % lower LL-37 compared to the healthy controls (P = 0.018), although 1,25(OH)2D3 was not predictive of higher LL-37 (P = 0.28). Finally, LL-37 levels were significantly lower in the HIV+/ART− group compared to the HIV+/ART+ group from the second cohort (P = 0.045). Untreated HIV infection may contribute to lower LL-37 levels, independent of vitamin D levels. ART treatment may potentially mitigate this decrease in LL-37 levels.
AllavenaC., DelpierreC., CuzinL., ReyD., VigetN., BernardJ., GuillotP., DuvivierC., BillaudE., RaffiF.2012; High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother 67:2222–2230 [View Article][PubMed]
BangU. C., ShakarS. A., HitzM. F., JespersenM. S., AndersenO., NielsenS. D., JensenJ. E.2010; Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study. Scand J Infect Dis 42:306–310 [View Article][PubMed]
BelecL., MeilletD., GaillardO., PrazuckT., MichelE., Ngondi EkomeJ., PillotJ.1995; Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS. Clin Exp Immunol 101:100–106 [View Article][PubMed]
CampbellG. R., SpectorS. A.2012a; Autophagy induction by vitamin D inhibits both Mycobacteriumtuberculosis and human immunodeficiency virus type 1. Autophagy 8:1523–1525 [View Article][PubMed]
CampbellG. R., SpectorS. A.2012b; Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacteriumtuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog 8:e1002689 [View Article][PubMed]
CrutchleyR. D., GatheJ.Jr, MayberryC., TrieuA., AbughoshS., GareyK. W.2012; Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses 28:454–459[PubMed]
DixonB. M., BarkerT., McKinnonT., CuomoJ., FreiB., BorregaardN., GombartA. F.2012; Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res Notes 5:575 [View Article][PubMed]
DürrU. H., SudheendraU. S., RamamoorthyA.2006; LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758:1408–1425 [View Article][PubMed]
FowlerM. G., MelnickS. L., MathiesonB. J.1997; Women and HIV. Epidemiology and global overview. Obstet Gynecol Clin North Am 24:705–729 [View Article][PubMed]
GolevaE., SearingD. A., JacksonL. P., RichersB. N., LeungD. Y.2012; Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma. J Allergy Clin Immunol 129:1243–1251 [View Article][PubMed]
HowellA. L., GrovemanD. S., WallaceP. K., FangerM. W.1997; HIV-1-infected monocytes and monocyte-derived macrophages are impaired in their ability to produce superoxide radicals. Int J Clin Lab Res 27:111–117 [View Article][PubMed]
JengL., YamshchikovA. V., JuddS. E., BlumbergH. M., MartinG. S., ZieglerT. R., TangprichaV.2009; Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 7:28 [View Article][PubMed]
LevinsonP., ChoiR. Y., ColeA. L., HirbodT., RhedinS., PayneB., GuthrieB. L., BosireR., ColeA. M.& other authors (2012; HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PLoS ONE 7:e31996 [View Article][PubMed]
ReddS. C., RutherfordG. W.III, SandeM. A., LifsonA. R., HadleyW. K., FacklamR. R., SpikaJ. S.1990; The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 162:1012–1017 [View Article][PubMed]
SegalL. N., MethéB. A., NolanA., HoshinoY., RomW. N., DawsonR., BatemanE., WeidenM. D.2011; HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc 8:282–287 [View Article][PubMed]
TwiggH. L.III, SpainB. A., SolimanD. M., BowenL. K., HeidlerK. M., WilkesD. S.1996; Impaired IgG production in the lungs of HIV-infected individuals. Cell Immunol 170:127–133 [View Article][PubMed]
Van Den Bout-Van Den BeukelC. J., FievezL., MichelsM., SweepF. C., HermusA. R., BoschM. E., BurgerD. M., BravenboerB., KoopmansP. P., Van Der VenA. J.2008; Vitamin D deficiency among HIV type 1-infected individuals in The Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 24:1375–1382 [View Article][PubMed]
VelascoM., CastillaV., SanzJ., GasparG., CondesE., BarrosC., CerveroM., TorresR., GuijarroC.COMESEM Cohort2009; Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immune Defic Syndr 50:148–152 [View Article][PubMed]
VesciniF., Cozzi-LepriA., BorderiM., ReM. C., MaggioloF., De LucaA., CassolaG., VulloV., CarosiG.& other authors (2011; Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J Acquir Immune Defic Syndr 58:163–172 [View Article][PubMed]
ViardJ. P., SouberbielleJ. C., KirkO., ReekieJ., KnyszB., LossoM., GatellJ., PedersenC., BognerJ. R.& other authors (2011; Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 25:1305–1315 [View Article][PubMed]
YamshchikovA. V., KurbatovaE. V., KumariM., BlumbergH. M., ZieglerT. R., RayS. M., TangprichaV.2010; Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr 92:603–611 [View Article][PubMed]